Most recently, it's been determined that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in comparable areas as classical opioid receptors, it binds to your big range of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger and won't activate a second messenger syste